z-logo
open-access-imgOpen Access
The Puzzling Role of TRAIL in Endothelial Cell Biology
Author(s) -
Paola Secchiero,
Giorgio Zauli
Publication year - 2008
Publication title -
arteriosclerosis thrombosis and vascular biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.007
H-Index - 270
eISSN - 1524-4636
pISSN - 1079-5642
DOI - 10.1161/atvbaha.107.158451
Subject(s) - endothelial stem cell , apoptosis , tumor necrosis factor alpha , flow cytometry , microbiology and biotechnology , biology , umbilical vein , downregulation and upregulation , immunology , cell , genetics , in vitro , gene
To the Editor:In their study published online in Arteriosclerosis, Thrombosis, and Vascular Biology , O’Brien et al demonstrate that activated protein C (APC) decreases tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) expression in endothelial cells.1 Although the molecular mechanism by which APC decreases the expression of TRAIL mRNA and protein via an Egr-1/Erk-1/2 pathway appears convincing, much less clear is whether the downregulation of TRAIL reflects a physiological relevant decrease of surface TRAIL or TRAIL release by endothelial cells. In fact, we have never detected surface TRAIL by flow cytometry in human umbilical vein endothelial cells (HUVECs), cultured with or without TNF-α (Figure). On the other hand, surface …

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom